Jiangwei Hu

机构：Hebei Medical University, Hubei University of Chinese Medicine, Beijing Jiaotong University, Hubei University of Arts and Science, Xingtai People's Hospital · ORCID：0000-0002-8976-2022

发表论文 41 篇 · 总被引 363 次 · h-index 12

代表论文

• Efficacy of intracellular immune checkpoint-silenced DC vaccine (2018 · JCI Insight · 被引 44)
• CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report (2021 · Frontiers in Immunology · 被引 23)
• Hypoxia-related gene signature for predicting LUAD patients’ prognosis and immune microenvironment (2022 · Cytokine · 被引 21)
• Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral stationary phase with high separation factor (2020 · Journal of Chromatography A · 被引 19)
• Hypomethylation-Mediated AGR2 Overexpression Facilitates Cell Proliferation, Migration, and Invasion of Lung Adenocarcinoma (2021 · Cancer Management and Research · 被引 13)
• Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study (2025 · Renal Failure · 被引 12)